Claims about EMF safety often rely on the idea that there is a single, unified scientific consensus. In reality, research on EMFs spans engineering, physics, biology, medicine, epidemiology, and public health — each with different assumptions and endpoints.

When people say “the science shows it’s safe”, they are usually referring to a specific subset of studies and standards that are carefully curated by lobbyists, industry, and lawmakers, not the entire research landscape. Understanding this distinction is essential to making sense of the debate.

Most regulatory standards for EMFs are based on avoiding acute thermal effects — in other words, preventing tissue heating over short periods of exposure.

Many independent studies, by contrast, investigate non-thermal biological effects such as oxidative stress, neurological changes, DNA damage, or altered cellular signalling, often under chronic or low-level exposure conditions.

Much of the research used to support regulatory limits is funded or shaped by industry and governmental bodies whose primary mandate is to enable widespread deployment of wireless technologies.

These studies tend to focus on compliance with existing exposure limits and on outcomes that are unlikely to disrupt established standards. This does not require bad faith — incentives alone are sufficient.

Organisations such as the World Health Organization (WHO), the International Commission on Non-Ionizing Radiation Protection (ICNIRP), and the U.S. Federal Communications Commission (FCC) base their guidance primarily on established exposure limits designed to prevent acute thermal harm.

These bodies are not tasked with adjudicating all possible biological effects. Their role is to set pragmatic standards for technology deployment under conditions of uncertainty.